PolyPeptide Group AG (LON:0AAJ)
London · Delayed Price · Currency is GBP · Price in CHF 25.90
+0.58 (2.29%)
At close: Sep 17, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 794.98 million as of September 18, 2025. Its market cap has decreased by -19.68% in one year.
Market Cap
794.98M
Enterprise Value
825.07M
Revenue
316.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.90
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 794.98M, a decrease of -61.02%. That is a compound annual growth rate of -19.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 802.16M | -2.80% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
| Apr 29, 2021 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 59.54B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |